Tonight on Nightly Business Report, Sprint shares fall almost 20% after ending its bid for T-Mobile. Now, the company has to find new growth the hard way.
And, what happens when unapproved drugs are the only hope for very ill patients. Tonight we start a three-part series ‘desperate measures.’
Hosts
Top Stories from CNBC- Brent crude breaks $70 after Saudi Arabia's oil facilities attacked by Yemen's Houthis
- Futures slip after Senate passes $1.9 trillion Covid relief bill
- U.S. hits record daily Covid vaccinations but health officials warn against loosening restrictions
- NBA Commissioner Adam Silver supports new league that pays high schoolers $100,000
- Investors haven't fully grasped inflation is 'dead ahead,' economist Mark Zandi warns
